Iran, Islamic Republic of vs Naoero: Immunization, measles second dose
Iran, Islamic Republic of
99.0%
in 2024
Naoero
99.0%
in 2024
Iran, Islamic Republic of rank
1st
Naoero rank
1st
Immunization, measles second dose over time
- Iran, Islamic Republic of
- Naoero
How they compare
Iran, Islamic Republic of currently reports 99.0% against 99.0% in Naoero, a difference of 0.0%.
The two have swapped places 6 times across 24 shared years of data; in 2001 it was Naoero ahead.
Iran, Islamic Republic of ranks 1st and Naoero ranks 1st of 178 countries.
Across the 3 decades both report, Iran, Islamic Republic of averaged higher in 2 and Naoero in 1.
Head to head by decade
| Decade | Iran, Islamic Republic of | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.3% | 83.0% | 13.3% | Iran, Islamic Republic of |
| 2010s | 98.0% | 93.7% | 4.3% | Iran, Islamic Republic of |
| 2020s | 98.4% | 98.6% | 0.2% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Iran, Islamic Republic of or Naoero?
- Iran, Islamic Republic of, at 99.0% against 99.0% in Naoero as of 2024.
- What is the difference in immunization, measles second dose between Iran, Islamic Republic of and Naoero?
- 0.0%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Naoero?
- 24 years are reported by both, from 2001 to 2024.
- How do Iran, Islamic Republic of and Naoero rank globally for immunization, measles second dose?
- Iran, Islamic Republic of ranks 1st and Naoero ranks 1st of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.